Gardnerella vaginalis (Bacterial vaginosis)

8,859views

Gardnerella vaginalis (Bacterial vaginosis)

Reproductive and Breast

Reproductive and Breast

Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Breast cancer screening: Clinical sciences
Breast cyst: Clinical sciences
Breast papilloma: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Emergency contraception: Clinical sciences
Infertility: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Bacterial vaginosis: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Uterine leiomyoma: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvar skin disorders (benign): Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Adenomyosis: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Endometriosis: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences
Cervical cancer screening: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Endometrial intraepithelial neoplasia (hyperplasia) and carcinoma: Clinical sciences
Gestational trophoblastic disease (GTD) and neoplasia (GTN): Clinical sciences
Ovarian cancer: Clinical sciences
Vulvar dysplasia and vulvar cancer: Clinical sciences
Adnexal torsion: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Testicular cancer: Clinical sciences
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Male pelvis and perineum
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Haemophilus ducreyi (Chancroid)
Neisseria gonorrhoeae
Staphylococcus aureus
Treponema pallidum (Syphilis)
Candida
Trichomonas vaginalis
Herpes simplex virus
Human papillomavirus
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Amenorrhea: Pathology review
Cervical cancer: Pathology review
Ovarian cysts and tumors: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Penile conditions: Pathology review
Prostate disorders and cancer: Pathology review
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors

Transcript

Watch video only

Gardnerella vaginalis, or G. Vaginalis for short, is a gram-variable coccobacillus present in low numbers in normal vaginal flora.

Normally, the vaginal flora is made up mostly of Lactobacilli, which keep vaginal pH below 4.5.

When the number of Lactobacilli decreases, that results in an imbalance of vaginal flora which increases the vaginal pH.

This allows G. vaginalis to proliferate, causing Bacterial Vaginosis, or BV which is the most common vaginal infection in females of reproductive age.

Now, G. vaginalis is gram-variable, which means it can stain either positive or negative with Gram-staining.

Ok, so normally, whether a bacteria is Gram-positive or Gram-negative is determined by the amount of peptidoglycan in their cell wall.

Bacteria with a thick peptidoglycan wall take in the purple dye used during Gram staining, so they’re Gram-positive.

Bacteria with a thin peptidoglycan wall can’t retain the purple dye, and instead stain pink with the Safranin dye used during Gram-staining.

So, Gram-variable bacteria, like G. vaginalis, first appear Gram-positive and then, as the culture ages, they gradually lose the peptidoglycan in their wall, and once their wall is too thin to retain purple color, they become Gram-negative.

Finally, G. vaginalis is non-spore forming, non-motile and facultative anaerobic which means it can survive in both aerobic and anaerobic environments.

Now, when vaginal pH increases, G. vaginalis can use a number of virulence factors to cause disease.

What is more, along with G. vaginalis, a number of other anaerobic bacteria species can proliferate, like Mobiluncus, Bacteroides or Prevotella which are also present in low numbers in normal vaginal flora - resulting in a mixed infection.

Ok, now, G. vaginalis produces a cytotoxin called vaginolysin and an enzyme called sialidase, and both of these help it adhere to the vaginal epithelial cells and colonize the vaginal epithelium.

Also, sialidases can cleave the sialic acid residues that keep the vaginal epithelial cells in place, so this makes easier for cells to detach from one another, causing desquamation of the epithelium.

Then, G. vaginalis produces proteolytic carboxylase enzymes which will break down vaginal peptides into volatile amines, which have an unpleasant smell.

Once they colonize the epithelium, the bacteria multiply and form a bacterial biofilm.

A biofilm is basically a layer of goop-like material made of exopolysaccharides or eps, within which bacteria live and reproduce.

Comparing a biofilm to strawberry jam, the seeds would be the bacteria and the rest of the jam would be the EPS. In this biofilm, the bacteria can hide from the host’s immune system and antibiotics.

Left untreated, the bacterial infection can spread to the cervix, causing cervicitis, and from there, make its way to the uterus, causing endometritis.

Now, risk factors for developing Bacterial Vaginosis are factors that alter the normal vaginal flora.

More specifically, these factors decrease the number of Lactobacilli which normally predominate in the vagina.

One such risk factor is having a new sexual partner, or multiple sexual partners - however, Bacterial Vaginosis is not a sexually transmitted infection, as it doesn’t colonize the male reproductive tract, so it is solely a bacterial imbalance of the female reproductive system.

Key Takeaways

Gardnerella vaginalis is a gram-variable coccobacillus, non-motile and facultative anaerobic bacterium, known to cause bacterial vaginosis (BV). This is a condition where the natural balance of bacteria in the vagina is disrupted and replaced by an overgrowth of certain bacteria. The symptoms of BV include discharge from the vagina that may be white, gray, or green; a strong fishy odor; and vaginal itching. BV is a common condition and is usually treated with antibiotics.